Patent · US Active

Use of compound that inactivates protein kinase A in a composition containing a cosmetically acceptable medium for lightening the skin

US7871635B2 · kind B2 · utility

5Cited by

9References

15Claims

0Family size

Assignee

SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC · FR

Inventors

Corinne Stolz · Thiais, FR
Christine Garcia · Castres, FR

Key dates

Filing date	Mar 16, 2009
Grant date	Jan 18, 2011
Priority date	—
Expiry date	Sep 22, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2800/782
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of using a compound to lighten the skin by inactivating protein kinase A. The compound may be in a composition with either a pharmacologically or cosmetically acceptable medium. Depending upon the medium and concentration of the compound, the composition may be used either therapeutically or non-therapeutically.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.